The largest database of trusted experimental protocols

6 protocols using il 1a

1

Isolation and Culture of Cardiac Fibroblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human and rat cardiac fibroblasts were isolated and cultured as described previously26 (link),27 . In short, cardiac tissue was washed and digested using collagenase (Worthington type II). Fibroblasts were separated from other cardiac cells by adherence for 1 hour to cell culture flasks. Primary fibroblasts were used up to passage 3. To determine regulation and effects of CILP1, cells were serum-starved for 24 hours before incubation with TGFβ1 (1 ng/ml), IL-1a (1 ng/ml), IGF1 (100 ng/ml) and CILP1 (100 ng/ml) for the indicated time (All obtained from R&D Systems). Adult and neonatal cardiomyocytes were isolated and cultured as described previously28 (link),29 (link). To inhibit TGFβ type 1 receptor, cells were incubated in serum-containing culture medium for 24 hrs with SB431542 (10 µM, Sigma).
+ Open protocol
+ Expand
2

Overexpression of Codon-Optimized ELTD1 in Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human umbilical cord endothelial cells (HUVECs) and human microvascular cells (HMEC-1) were purchased from Lonza (Basel, Switzerland) and cultured in their EGM2 and EGM2-MV media respectively. IL8 and IL1a (R&D Systems, Minneapolis, MN, USA) were added to cells at 10 ng/mL. IL1-receptor antagonist (Sigma, St. Louis, MO, USA) was added at 1 μg/mL. The endogenous sequence of ELTD1 is poorly expressed therefore the cDNA was codon optimised using the JCat bioinformatics tool (http://www.jcat.de/) (accessed on 31 November 2017) without altering the amino acid coding sequence. Codon optimised ELTD1 (coELTD1) and HA-tagged coELTD1 were cloned into pLenti6.2V5DEST (ThermoFisher, Waltham, MA, USA) and the vector alone was used as a control. Virus was produced in 293T and concentrated by ultracentrifugation using standard techniques. The viruses were titred using blasticidin resistance and endothelial cells infected at MOI 5 for all experiments.
+ Open protocol
+ Expand
3

Astrocyte-Derived Exosome Isolation

Check if the same lab product or an alternative is used in the 5 most similar protocols
DPBS-washed astrocytes were seeded into new culture flasks (107 cells/flask) and cultured in a medium containing FBS without exosomes (SBI System Biosciences, Palo Alto, CA, USA). Some 12 h later, the cells were stimulated with a cocktail of proinflammatory cytokines: IL-1a (10 ng/mL, R&D Systems, Ixonia, WI, USA), TNF-α (30 ng/mL, R&D Systems), C1q (400 ng/mL, R&D Systems). Alternative phenotypes of astrocytes were induced by IL-10 (10 ng/mL) or TGF-β (10 ng/mL) stimulation (both cytokines from R&D Systems). Astrocytes cultured without cytokines were also included. In our previous work, we characterized the secretory activity of astrocytes in response to these stimuli [81 (link)]. After a six-day culture, the media were collected and centrifuged (300× g, 10 min, 20 °C) and the supernatants were centrifuged again (16,000× g, 30 min, 20 °C). Next, the exosomes were precipitated (12 h, 4 °C) with exosome precipitation reagent (Exo-spin Buffer, CellGS, Cambridge, UK) and centrifuged (16,000× g, 1.5 h, 20 °C). The supernatants were removed and the pellets were resuspended in PBS and purified on exosome size-exclusion columns (Exo-spin, Cell Guidence Systems, Cambridge, UK) according to a protocol provided by the assay manufacturer. After purification, the exosomes were aliquoted and frozen for further procedures.
+ Open protocol
+ Expand
4

Cytokine Screening of Dendritic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dendritic cells were exposed to 1.3 μg/mL TNFα (Symansis), 9 μg/mL CCL3 (Symansis), 3.8 μg/mL IL8 (Symansis), 20 μg/mL CXCL10 (Peprotech), 0.5 μg/mL CCL5 (Peprotech), 9 μg/mL IL6 (Peprotech), 2.8 μg/mL IFNα2 (PBL InterferonSource), 0.03 μg/mL CXCL12 (Peprotech), 2 μg/mL IFNALPHA16 (PBL InterferonSource), 0.03 μg/mL IL12a (Symansis), 4.4 μg/mL IL18 (R&D SYSTEMS), 0.2 μg/mL IL1a (R&D SYSTEMS), 1 μg/mL IL1RA (R&D SYSTEMS), 4 μg/mL IL28a (AbD Serotec), 4 μg/mL IL29 (R&D SYSTEMS), 0.1 μg/mL TNFSF15 (AbD Serotec), 0.1 μg/mL TNFSF4 (R&D Systems), 0.1 μg/mL TNFSF10 (R&D Systems), 0.2 μg/mL IL1β (eBiosciences), and 8.89 μg/mL IFNβ (PBL InterferonSource) in various combinations for 8 h. For the first screening with 20 cytokines, we used cells from three different donors. To adjust for overall differences between individuals, we normalized data of each individual to the median of all treatments. All other cytokine screening experiments were carried out with replicated from the same donor and then repeated with at least two additional donors.
+ Open protocol
+ Expand
5

Quantifying Inflammatory Mediators

Check if the same lab product or an alternative is used in the 5 most similar protocols
Media from the tissue explants were assayed using a sandwich ELISA to determine the protein concentrations of IL6, GM-CSF and CXCL8 (Life Technologies) and IL1A, IL1B, CCL2, CXCL1 and CXCL5 (R&D Systems) as according to the manufacturer's instructions. The release of PGF 2α into the incubation medium was also assayed using a commercially available competitive enzyme immunoassay kit according to the manufacturer's instructions (Cayman Chemical Company). The 563 Reproduction (2020) 160 561-578 calculated interassay and intraassay coefficients of variation (CV) were all less than 10%.
+ Open protocol
+ Expand
6

Serological Biomarkers for Cancer Prognosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serological marker measurement was performed using ELISA kits according to the manufacturer's protocols: IL4 (D4050), TIMP1 (DTM100), IL3 (D3000), IL1A (DLA50), PDGFB (DBB00), TEK (or TIE2, DTE200), PECAM1 (DCD310), MMP2 (MMP200), pro‐MMP10 (DM1000), KLK3/PSA (DKK300), free IGFBP1 (DGB100), CX3CL1 (DCX310), IL19 (D1900) (all R&D SYSTEMS); and YAP (LifeSpan BioSciences, Inc., LS‐F49700). A calibration curve was generated using known concentrations of analyte. Samples were further diluted and reassayed if readings were above the linear range of the calibration curve. Data are reported as mean ± SD. ELISA kits details used for serological marker measurement are listed in Table S3. The degree of correlation between blood markers and patient PFS were evaluated to choose potential biomarkers for predicting responses to treatment or disease prognosis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!